AI Perception Is Setting Software Valuations. It Is Not Setting Your Credit.
As of July 2026, the multiple a recurring-revenue technology company carries depends more on its AI narrative than on the revenue it has already contracted, and a lender reads only the second one.
Two software companies can carry identical annual recurring revenue, identical margins, and identical retention, and still be valued several turns of revenue apart. As of July 10, 2026, the variable separating them is not scale, growth, or profitability. It is how the market reads their exposure to artificial intelligence, either as an application advantage or as a disruption risk. For a founder deciding how to fund the next year of growth, that distinction is expensive, because equity carries the narrative and debt does not.
The market is pricing a story, and the story is AI
Public software valuations are now being set primarily by perceived AI application strength or AI-disruption risk rather than by total addressable market or company size. The dispersion this produces is stark. As of July 9, 2026, the median public SaaS company traded at 3.04x revenue while the average sat at 5.28x, across a set of 143 companies growing 14.33% on average. When the average runs well above the median, a minority of names are carrying a large premium and pulling the mean away from the middle, while most companies sit at or below 3x. The multiple is measuring a forward story about AI positioning, not the revenue already on the books. That is a fine way to price a bet. It is a poor way to price the capital that funds a real, contracted business.
Identical companies, different marks
Underneath the median, the gap between the best-marked and worst-marked software companies is as wide as it has been in years. Two companies with identical ARR are now valued at prices that differ by three to four turns of revenue, separated by the same handful of variables: AI defensibility, net revenue retention, profitability, and the process behind the deal. Public top-quartile SaaS traded at 6.4x as of late June 2026 against a bottom quartile of 2.5x, and companies with net revenue retention above 120% still command 8x or more, while the slowest-growing names trade near 1.9x regardless of whether they book $200M or $2B in revenue (late-June index data, used here as supporting context). Take two recurring-revenue technology companies at $10M ARR. One is marked at 8x and valued near $80M. The other is marked at 3x and valued near $30M. Same contracts, same margins, roughly $50M of value between them, decided by perception rather than by anything on the income statement.
What a lender reads instead
A credit underwriter does not price an AI narrative. It reads the contract base, the gross margin, the retention curve, and the customer concentration. A recurring-revenue technology company with gross margin above 50%, proven product-market fit, and a stable customer base is a clean credit whether or not the equity market has decided it is an AI winner. This is the mismatch that matters. The same set of contracts that the public market marks down on sentiment is the exact asset a lender underwrites at face value. A founder who raises equity in this environment sells ownership at a price set by a story that is currently producing the widest multiple dispersion in years. If the story shifts, and AI-driven repricing has already moved the public median to its lowest level since 2011, the dilution does not come back.
How Thalos Capital Approaches This
Recurring Revenue Debt underwrites the contracted revenue and the margin profile, not the equity multiple. Thalos Capital structures non-dilutive facilities around ARR rather than around a valuation. The Interest-Only Facility fits companies above $5M ARR, with interest-only payments across a two to three year term and a balloon at maturity. The Amortized Term Facility fits companies between $2M and $20M ARR, where principal ladders up as recurring revenue grows. Common eligibility is a recurring-revenue technology business in the United States or Canada, product-market fit demonstrated across at least ten clients, and gross margin above 50%. The mechanism is deliberately narrow. It funds the growth plan on what the company has already booked, with no dilution, no board seats, and no warrants, and without asking a founder to accept an AI-narrative discount as the price of capital. The point is not that debt is always cheaper than equity. It is that pricing capital off a contract base is a different, and frequently better, decision than pricing it off a multiple the market is setting on a story.
The cost of the wrong move
The founder who funds next year with equity locks in a valuation set by AI sentiment at the moment that sentiment is at its most volatile. The company whose contracts are strong enough to borrow against does not need to accept that price to grow. Reading the difference between what the market marks and what a lender underwrites is the analytical step most founders skip, and it is the one that decides how much of the company they still own in two years.
Most financing situations have more options than the borrower initially sees. A conversation is enough to map them. Submit your financing request at https://thaloscapital.com/contact.
